These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 157648)

  • 1. [Functional significance of the clotting and anticlotting of the blood in the development of malignant neoplasms in the body].
    Kudriashov BA; Kalishevskaia TM; Kolomina SM
    Usp Fiziol Nauk; 1979; 10(2):3-23. PubMed ID: 157648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the blood coagulation system and fibrinolysis during growth and metastasis of malignant neoplasms].
    Bergut FA
    Sov Med; 1976 Apr; (4):45-51. PubMed ID: 790595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental data on the existence and significance of an anticoagulating system in fish].
    Kudriashov BA; Kalishevskaia TM; Bazaz'ian GG; Volkov VN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 2():31-6. PubMed ID: 4824513
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravascular blood coagulation and its role in malignant neoplasms].
    Pavlovskiĭ DP
    Vopr Onkol; 1981; 27(7):96-103. PubMed ID: 7023043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of substances that increase the activity of the anti-coagulating system of tumor-bearing animals on the growth of metastases and on the ultrastructure of the metastatic cells].
    Kudriashov BA; Kolomina SM; Chentsov IuS; Kalishevskaia TM; Pogodina LS
    Vopr Onkol; 1977; 23(12):77-81. PubMed ID: 146306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of intravascular coagulation processes].
    Moriau M; Masure R
    Nouv Rev Fr Hematol; 1968; 8(1):5-19. PubMed ID: 4232151
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombophilia in cancer.
    Falanga A
    Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale of anticoagulants in the treatment of cancer.
    Cliffton EE; Grossi CE
    J Med; 1974; 5(1):107-13. PubMed ID: 4275504
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis.
    Gabryelewicz A; Niewiarowski S
    Thromb Diath Haemorrh; 1968 Dec; 20(3):409-14. PubMed ID: 4237139
    [No Abstract]   [Full Text] [Related]  

  • 13. The induction of thrombosis in guinea pigs by a brain tumor.
    Odom MH; Hurt JP; Krigman MR
    Lab Invest; 1972 Dec; 27(6):550-4. PubMed ID: 4345172
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
    Straub PW
    Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
    Uchiyama T; Andoh K; Tanaka H; Kobayashi N; Naruse T; Maekawa T
    Rinsho Byori; 1990 Jul; Suppl 86():125-33. PubMed ID: 2232233
    [No Abstract]   [Full Text] [Related]  

  • 16. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
    Moriau M
    Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
    [No Abstract]   [Full Text] [Related]  

  • 17. [The physiologic coagulation fibrinolytic system of the body and thrombohemorrhagic theory in oncology].
    Nadiradze ISh; Machabeli MS
    Usp Fiziol Nauk; 1989; 20(4):94-109. PubMed ID: 2688336
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
    Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between the hemostatic process and thrombosis. A clinical problem].
    Ponari O; Dettori AG
    Recenti Prog Med; 1968 Sep; 45(3):259-82. PubMed ID: 4916345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.